Month: November 2016
-
Company Launches to Discover Gut-Brain Therapies
A California Institute of Technology biologist is starting a new enterprise to discover treatments for neurological disorders through pathways originating in the gut.
-
Small Business Grant Funding Retractable Flood Walls
A University at Buffalo graduate student in engineering took an idea for space-efficient flood control walls to protect waterfront properties, and started a company to take the idea to market.
-
Regeneron, Children’s National Partner on Rare Diseases
Regeneron Genetics Center and Children’s National Health System have begun studying thousands of genetic profiles to better understand the causes of rare and undiagnosed disorders.
-
Biodegradable Capsule Designed for Hemophilia Drug
A chemical engineering group designed a capsule to deliver blood coagulating proteins for people with hemophilia B who now require injections or infusions.
-
Liquid Biopsy Better Detects Lung Cancer Mutations
Tests of blood and urine from patients with a common form of lung cancer show these liquid biopsies more accurately identified cancer-causing mutations than traditional tissue sample biopsies.
-
Another Thanksgiving Tradition
24 November 2015. Today begins Thanksgiving weekend in the United States, a day of family gatherings, feasting, football, and (for some) shopping. Last year was also the 50th anniversary of the counterculture anthem for Thanksgiving, Arlo Guthrie’s Alice’s Restaurant, a song about Thanksgiving and a lot more. And as we did last year, here’s Arlo…
-
Nylon Fibers Given Muscle-Like Bending Properties
Research engineers at MIT designed a process that gives ordinary nylon fibers the ability to bend and flex like artificial muscles.
-
Engineered T-Cell Trial Halted After Participant Dies
A clinical trial testing treatments that modify immune system cells to fight leukemia in adults was stopped after one of the patients died from inflammation in the brain.
-
Partnership Assessing Nerve Stimulation Bleeding Device
The Feinstein Institute for Medical Research and Global Good Fund are evaluating an electronic device that stimulates nerves to stop bleeding, as a way to control postpartum hemorrhage
-
Targeted Leukemia Drugs Sharply Raising Costs of Care
Drugs directly attacking cancer cell growth show high remission rates with a common form of leukemia, but a new study suggests the high costs of these drugs could impose difficult economic burdens on patients and the health care system.